nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—DDC—telencephalic ventricle—brain cancer	0.0927	0.179	CbGeAlD
Cycloserine—Neurological symptom—Lomustine—brain cancer	0.0897	0.199	CcSEcCtD
Cycloserine—DDC—pineal body—brain cancer	0.0804	0.155	CbGeAlD
Cycloserine—SLC36A2—gonad—brain cancer	0.0743	0.143	CbGeAlD
Cycloserine—DDC—ganglion—brain cancer	0.0577	0.111	CbGeAlD
Cycloserine—SLC36A2—endocrine gland—brain cancer	0.0561	0.108	CbGeAlD
Cycloserine—DDC—hindbrain—brain cancer	0.0437	0.0843	CbGeAlD
Cycloserine—Dysarthria—Lomustine—brain cancer	0.0286	0.0635	CcSEcCtD
Cycloserine—Paresis—Temozolomide—brain cancer	0.0285	0.0632	CcSEcCtD
Cycloserine—DDC—brainstem—brain cancer	0.0251	0.0483	CbGeAlD
Cycloserine—DDC—telencephalon—brain cancer	0.0223	0.0429	CbGeAlD
Cycloserine—Disorientation—Lomustine—brain cancer	0.022	0.0487	CcSEcCtD
Cycloserine—Osteoarthritis—Lomustine—brain cancer	0.0197	0.0436	CcSEcCtD
Cycloserine—Dysarthria—Procarbazine—brain cancer	0.0182	0.0403	CcSEcCtD
Cycloserine—DDC—midbrain—brain cancer	0.016	0.0308	CbGeAlD
Cycloserine—Coma—Procarbazine—brain cancer	0.0157	0.0348	CcSEcCtD
Cycloserine—DDC—endocrine gland—brain cancer	0.014	0.0271	CbGeAlD
Cycloserine—Disorientation—Procarbazine—brain cancer	0.0139	0.0309	CcSEcCtD
Cycloserine—DDC—head—brain cancer	0.0139	0.0267	CbGeAlD
Cycloserine—DDC—central nervous system—brain cancer	0.0126	0.0244	CbGeAlD
Cycloserine—Disorientation—Hydroxyurea—brain cancer	0.0108	0.0239	CcSEcCtD
Cycloserine—DDC—brain—brain cancer	0.01	0.0194	CbGeAlD
Cycloserine—Coma—Carmustine—brain cancer	0.00983	0.0218	CcSEcCtD
Cycloserine—Drowsiness—Procarbazine—brain cancer	0.00962	0.0213	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00942	0.31	CbGpPWpGaD
Cycloserine—Drowsiness—Hydroxyurea—brain cancer	0.00744	0.0165	CcSEcCtD
Cycloserine—Tremor—Procarbazine—brain cancer	0.00704	0.0156	CcSEcCtD
Cycloserine—Cardiac failure congestive—Etoposide—brain cancer	0.00666	0.0148	CcSEcCtD
Cycloserine—Convulsion—Procarbazine—brain cancer	0.00651	0.0144	CcSEcCtD
Cycloserine—Confusional state—Procarbazine—brain cancer	0.00618	0.0137	CcSEcCtD
Cycloserine—Paraesthesia—Procarbazine—brain cancer	0.00551	0.0122	CcSEcCtD
Cycloserine—Somnolence—Procarbazine—brain cancer	0.00545	0.0121	CcSEcCtD
Cycloserine—Feeling abnormal—Procarbazine—brain cancer	0.00505	0.0112	CcSEcCtD
Cycloserine—Convulsion—Hydroxyurea—brain cancer	0.00504	0.0112	CcSEcCtD
Cycloserine—Hypersensitivity—Procarbazine—brain cancer	0.00452	0.01	CcSEcCtD
Cycloserine—Tremor—Carmustine—brain cancer	0.0044	0.00977	CcSEcCtD
Cycloserine—Tremor—Temozolomide—brain cancer	0.00426	0.00944	CcSEcCtD
Cycloserine—Somnolence—Hydroxyurea—brain cancer	0.00422	0.00936	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—GLI2—brain cancer	0.0041	0.135	CbGpPWpGaD
Cycloserine—Vertigo—Temozolomide—brain cancer	0.00408	0.00905	CcSEcCtD
Cycloserine—Convulsion—Carmustine—brain cancer	0.00407	0.00904	CcSEcCtD
Cycloserine—Convulsion—Temozolomide—brain cancer	0.00394	0.00873	CcSEcCtD
Cycloserine—Feeling abnormal—Hydroxyurea—brain cancer	0.00391	0.00868	CcSEcCtD
Cycloserine—Confusional state—Carmustine—brain cancer	0.00387	0.00858	CcSEcCtD
Cycloserine—Rash—Procarbazine—brain cancer	0.00387	0.00858	CcSEcCtD
Cycloserine—Dermatitis—Procarbazine—brain cancer	0.00386	0.00857	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—GLI1—brain cancer	0.00386	0.127	CbGpPWpGaD
Cycloserine—Headache—Procarbazine—brain cancer	0.00384	0.00852	CcSEcCtD
Cycloserine—Confusional state—Temozolomide—brain cancer	0.00374	0.00829	CcSEcCtD
Cycloserine—Hypersensitivity—Hydroxyurea—brain cancer	0.0035	0.00776	CcSEcCtD
Cycloserine—Paraesthesia—Carmustine—brain cancer	0.00345	0.00764	CcSEcCtD
Cycloserine—Somnolence—Carmustine—brain cancer	0.00341	0.00757	CcSEcCtD
Cycloserine—Paraesthesia—Temozolomide—brain cancer	0.00333	0.00739	CcSEcCtD
Cycloserine—Somnolence—Temozolomide—brain cancer	0.0033	0.00731	CcSEcCtD
Cycloserine—Vertigo—Etoposide—brain cancer	0.00327	0.00725	CcSEcCtD
Cycloserine—Feeling abnormal—Carmustine—brain cancer	0.00316	0.00701	CcSEcCtD
Cycloserine—Convulsion—Etoposide—brain cancer	0.00315	0.00699	CcSEcCtD
Cycloserine—Feeling abnormal—Temozolomide—brain cancer	0.00306	0.00678	CcSEcCtD
Cycloserine—Rash—Hydroxyurea—brain cancer	0.00299	0.00664	CcSEcCtD
Cycloserine—Confusional state—Etoposide—brain cancer	0.00299	0.00664	CcSEcCtD
Cycloserine—Dermatitis—Hydroxyurea—brain cancer	0.00299	0.00663	CcSEcCtD
Cycloserine—Headache—Hydroxyurea—brain cancer	0.00297	0.0066	CcSEcCtD
Cycloserine—Hypersensitivity—Carmustine—brain cancer	0.00283	0.00627	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—SHH—brain cancer	0.00279	0.0917	CbGpPWpGaD
Cycloserine—Hypersensitivity—Temozolomide—brain cancer	0.00273	0.00606	CcSEcCtD
Cycloserine—Paraesthesia—Etoposide—brain cancer	0.00266	0.00591	CcSEcCtD
Cycloserine—Somnolence—Etoposide—brain cancer	0.00264	0.00585	CcSEcCtD
Cycloserine—Feeling abnormal—Etoposide—brain cancer	0.00245	0.00542	CcSEcCtD
Cycloserine—Rash—Carmustine—brain cancer	0.00242	0.00537	CcSEcCtD
Cycloserine—Dermatitis—Carmustine—brain cancer	0.00242	0.00536	CcSEcCtD
Cycloserine—Headache—Carmustine—brain cancer	0.0024	0.00533	CcSEcCtD
Cycloserine—Rash—Temozolomide—brain cancer	0.00234	0.00519	CcSEcCtD
Cycloserine—Dermatitis—Temozolomide—brain cancer	0.00234	0.00518	CcSEcCtD
Cycloserine—Headache—Temozolomide—brain cancer	0.00232	0.00515	CcSEcCtD
Cycloserine—Hypersensitivity—Etoposide—brain cancer	0.00219	0.00485	CcSEcCtD
Cycloserine—Rash—Etoposide—brain cancer	0.00187	0.00415	CcSEcCtD
Cycloserine—Dermatitis—Etoposide—brain cancer	0.00187	0.00415	CcSEcCtD
Cycloserine—Headache—Etoposide—brain cancer	0.00186	0.00412	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00165	0.0541	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CCNE1—brain cancer	0.00147	0.0483	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HES5—brain cancer	0.0014	0.0461	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NTRK3—brain cancer	0.00118	0.0389	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00076	0.025	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000757	0.0249	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000597	0.0196	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HES1—brain cancer	0.000463	0.0152	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—SIRT1—brain cancer	0.000392	0.0129	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CDK4—brain cancer	0.000297	0.00976	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000232	0.00764	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000205	0.00673	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2C9—brain cancer	0.000204	0.00671	CbGpPWpGaD
Cycloserine—DDC—Metabolism—BSG—brain cancer	0.000173	0.00571	CbGpPWpGaD
Cycloserine—DDC—Metabolism—IDH1—brain cancer	0.000149	0.00491	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TP53—brain cancer	0.000126	0.00415	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ENO2—brain cancer	0.000118	0.00388	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CG—brain cancer	5.41e-05	0.00178	CbGpPWpGaD
